stockrowRepligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −351.9%
- Free cash flow
- −11.5%
- Total debt
- +3.28%
Quarter to September 2026, against a year earlier
Follow RGEN
Alert me
Repligen Corporation (RGEN) Revenue growth
Repligen Corporation's revenue growth over the twelve months to 30 September 2026 was 13.8%, down 2.6 percentage points from fiscal 2025 (16.4%). Over the past ten years it has ranged from −21.1% (fiscal 2023) to 83.1% (fiscal 2021); the current reading is higher than 27% of that period. That is above the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 16.4% | 16.03 |
| FY2024 | 0.33% | 21.44 |
| FY2023 | −21.1% | (40.65) |
| FY2022 | 19.5% | (63.54) |
| FY2021 | 83.1% | 47.55 |
| FY2020 | 35.5% | (3.75) |
| FY2019 | 39.3% | 1.90 |
| FY2018 | 37.4% | 2.28 |
| FY2017 | 35.1% | 9.96 |
| FY2016 | 25.1% | (6.31) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 10.9% | (1.07) |
| Jun 2026 | 11.9% | (2.90) |
| Mar 2026 | 14.8% | (3.29) |
| Dec 2025 | 18.1% | (3.79) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| TFX Teleflex Incorporated compare | 30.7% |
| RGEN Repligen Corporation | 13.8% |
| ATR AptarGroup, Inc. compare | 8.97% |
| BLCO Bausch + Lomb Corporation compare | 8.88% |
| BAX Baxter International Inc. compare | 5.33% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| ALGN Align Technology, Inc. compare | 4.42% |
| AVTR Avantor, Inc. compare | 0.92% |
| SOLV Solventum Corporation compare | −2.84% |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on RGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement